Introduction and Summary of the Workshop “Drug Research Support: Selection and Early Development”

Burkhardt JE , Floyd E. , Kerlin RL , Adler RR , Ochoa R. , Reynolds JA (1999). A view on discovery pathology . Toxicol Pathol 27: 472—473.

Car BD , Robertson RT (1999). Discovery toxicology—A nascent science. Toxicol Pathol 27: 481—483.

Cockerell GL , Burkhardt JE , Ryan AM (1999). Focus on: Discovery pathology . Toxicol Pathol 27: 471.

Cockerell GL , Aaron CS , Moe JB (1999). Redesigning the preclinical paradigm: The role of pathology and toxicology in supporting discovery research . Toxicol Pathol 27: 477—478.

Germann PG , Häfner D. , Hanauer G. , Drommer W. (1998). J Exp Anim Sci 39: 22—33.

Harleman JH (1999). Contribution of pathology to drug research and development in the next decade. Toxicol Pathol 27: 479—480.

Ryan AM (1999). Role of the pathologist in the identification and characterization of therapeutic molecules. Toxicol Pathol 27: 474—476.

Schwetz BA (2000). Toxicology at the food and drug administration. Int Toxicol 20: 3—8.

STP Homepage (11.10.2000). Investigative Toxicology and Pathology Interest Group. www.toxpath.org/Intra.htm